CFX Opus 96 Real-Time PCR System

SOL #: 26-003418Combined Synopsis/Solicitation

Overview

Buyer

Health And Human Services
National Institutes Of Health
NATIONAL INSTITUTES OF HEALTH OLAO
BETHESDA, MD, 20892, United States

Place of Performance

CA

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

PSC

Laboratory Equipment And Supplies (6640)

Set Aside

No set aside specified

Timeline

1
Posted
May 12, 2026
2
Submission Deadline
May 22, 2026, 2:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The National Institutes of Health (NIH) is seeking proposals for a CFX Opus 96 Real-Time PCR System through a Combined Synopsis/Solicitation (RFQ). This acquisition aims to procure a real-time PCR system capable of multiplex nucleic acid detection and analysis, compatible with existing laboratory workflows. Proposals are due May 22, 2026, at 10:00 AM EDT.

Scope of Work

The requirement is for a real-time PCR system with specific features:

  • Capture up to five fluorophores in a single reaction well using "All Channels" scan mode, or one fluorophore using SYBR/FAM or FRET Scan Modes.
  • Fixed optical path directly over each well, eliminating the need for positional bias normalization or passive dye calibration.
  • Compact design without extending lid or drawer, fitting under a standard shelf (13x22x14 inches).
  • Ability to view real-time data traces during a run from the thermal cycler base or via CFX Maestro software.
  • CFX Maestro software must be compatible with older CFX system results to ensure project continuity.
  • Support combining multiple plates into one experiment with the Gene Study Feature on CFX Maestro software.
  • Software must perform t-tests and 1-way ANOVA calculations. The system, preferably from Bio-Rad, must provide multiplexing, thermal uniformity, and compatibility with existing lab workflows and data analysis software.

Contract & Timeline

  • Type: Combined Synopsis/Solicitation (Request for Quote - RFQ)
  • Contract Award Type: Firm Fixed Price
  • Set-Aside: Unrestricted
  • NAICS Code: 334516 (Small Business Size Standard: 1000 employees)
  • Response Due: May 22, 2026, at 10:00 AM EDT
  • Published: May 12, 2026
  • Place of Performance: Bethesda, MD

Evaluation

Award will be made to the responsible offeror whose offer is most advantageous to the Government, considering price and other factors. Evaluation factors include:

  • Technical
  • Past Performance
  • Cost Technical and Past Performance, when combined, are significantly more important than Cost. Offerors must include a completed FAR clause 52.212-3 (Offeror Representations and Certifications – Commercial Items) or ensure electronic completion via SAM.gov.

Additional Notes

This is a combined synopsis/solicitation for commercial items under FAR Part 12 and FAR Part 13 procedures. Offerors should refer to the addendum for FAR Clause 52.212-1 (Instructions to Offerors) for additional attachments, including the Statement of Work, and the addendum for FAR Clause 52.212-4 (Contract Terms and Conditions) for additional terms.

People

Points of Contact

Towanda DanielsPRIMARY

Files

Files

No files attached to this opportunity

Versions

Version 1Viewing
Combined Synopsis/Solicitation
Posted: May 12, 2026